1. Home
  2. CLGN vs OMH Comparison

CLGN vs OMH Comparison

Compare CLGN & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • OMH
  • Stock Information
  • Founded
  • CLGN 2004
  • OMH 2015
  • Country
  • CLGN Israel
  • OMH Singapore
  • Employees
  • CLGN N/A
  • OMH N/A
  • Industry
  • CLGN Industrial Specialties
  • OMH Real Estate
  • Sector
  • CLGN Health Care
  • OMH Finance
  • Exchange
  • CLGN Nasdaq
  • OMH Nasdaq
  • Market Cap
  • CLGN 33.8M
  • OMH 35.8M
  • IPO Year
  • CLGN N/A
  • OMH 2023
  • Fundamental
  • Price
  • CLGN $2.23
  • OMH $1.27
  • Analyst Decision
  • CLGN Strong Buy
  • OMH Hold
  • Analyst Count
  • CLGN 2
  • OMH 1
  • Target Price
  • CLGN $11.50
  • OMH N/A
  • AVG Volume (30 Days)
  • CLGN 250.5K
  • OMH 284.7K
  • Earning Date
  • CLGN 11-26-2025
  • OMH 09-25-2025
  • Dividend Yield
  • CLGN N/A
  • OMH N/A
  • EPS Growth
  • CLGN N/A
  • OMH N/A
  • EPS
  • CLGN N/A
  • OMH N/A
  • Revenue
  • CLGN $2,402,000.00
  • OMH $7,976,578.00
  • Revenue This Year
  • CLGN $1,617.28
  • OMH $28.40
  • Revenue Next Year
  • CLGN $83.54
  • OMH $23.07
  • P/E Ratio
  • CLGN N/A
  • OMH N/A
  • Revenue Growth
  • CLGN 248.62
  • OMH 117.53
  • 52 Week Low
  • CLGN $1.31
  • OMH $0.59
  • 52 Week High
  • CLGN $4.99
  • OMH $5.10
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 40.00
  • OMH 51.16
  • Support Level
  • CLGN $2.21
  • OMH $1.24
  • Resistance Level
  • CLGN $3.18
  • OMH $1.37
  • Average True Range (ATR)
  • CLGN 0.22
  • OMH 0.08
  • MACD
  • CLGN -0.06
  • OMH -0.00
  • Stochastic Oscillator
  • CLGN 6.00
  • OMH 47.57

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: